• Study of IDE849, IDE‑161 and durvalumab evaluating safety and efficacy in patients with DLL3‑positive tumors including small cell lung cancer

    Not yet recruiting

    1 1 1 1
    Investigated diseases:
    Investigated drugs:
    France Spain

  • A Randomized Controlled Trial of Cannabidiol vs Placebo Augmentation in Patients with First Episode Psychosis

    Not yet recruiting

    3 1 1
    Investigated drugs:
    Austria Germany Greece Italy The Netherlands Spain

  • Safety Study of VCN-01 with nab‑Paclitaxel and Gemcitabine in Newly Diagnosed Metastatic Pancreatic Cancer Patients

    Not yet recruiting

    2 1 1
    Investigated diseases:
    Investigated drugs:
    Spain

  • Micronised progesterone luteal-phase support improves live birth rates in women with unexplained infertility

    Not yet recruiting

    3 1 1
    Investigated diseases:
    Investigated drugs:
    The Netherlands

  • Dalbavancin versus standard drug combination for treatment of infective endocarditis caused by Gram‑positive cocci in adult patients

    Not yet recruiting

    3 1 1 1
    Investigated drugs:
    Germany

  • Phase 3 Study of Taletrectinib as Adjuvant Therapy in Patients with Completely Resected ROS1‑Positive Stage IB‑IIIA Non‑Small Cell Lung Cancer

    Not yet recruiting

    3 1
    Investigated drugs:
    Belgium France Germany Italy Spain

  • Safety and Tolerability of Inhaled KB707 with or without Docetaxel in Patients with Advanced Lung Solid Tumors

    Not yet recruiting

    1 1 1 1
    Investigated drugs:
    France Spain

  • Safety and Tolerability of Intrathecal ION337 in Patients with Dravet Syndrome

    Not yet recruiting

    2 1 1
    Investigated diseases:
    Belgium France Germany Portugal Spain

  • Study of hu14.18K322A with temozolomide and irinotecan in children and adolescents with high‑risk neuroblastoma

    Not yet recruiting

    4 1 1 1
    Investigated diseases:
    Investigated drugs:
    Denmark France Germany Ireland Spain

  • Study of Benralizumab Safety, Pharmacokinetics, and Efficacy in Children with Eosinophilic Disease

    Not yet recruiting

    3 1 1 1
    Investigated drugs:
    France The Netherlands Poland

powered by